<DOC>
	<DOC>NCT01897766</DOC>
	<brief_summary>The objective of this surveillance is to collect Safety and Effectiveness information for Long term Use of Somatropin for Patients with a Small for Gestational Age (SGA).</brief_summary>
	<brief_title>Special Investigation Of Genotropin Long Follow-Up For Patients With A Small For Gestational Age (SGA)</brief_title>
	<detailed_description>All the patients whom an investigator prescribes Genotropin should be registered consecutively until the number of subjects reaches target number in order to extract patients enrolled into the investigation at random.</detailed_description>
	<criteria>A patient who was administered Somatropin (Genotropin).</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Genotropin</keyword>
	<keyword>Somatropin</keyword>
	<keyword>Long Term Follow-Up</keyword>
	<keyword>Special Investigation</keyword>
	<keyword>Small for Gestational Age</keyword>
	<keyword>SGA</keyword>
</DOC>